Dr. Giorgio A. Medranda, MD

Dr. Medranda practices at NYU Langone Hospitals - Long Island in Mineola, New York.

Dr. Medranda's NPI, 1952713992, was assigned on May 26, 2014. Dr. Medranda graduated from State University of New York Downstate Medical Center College of Medicine in 2014. Dr. Medranda holds New York license 291359.

Dr. Medranda's primary practice is NYU Langone Hospitals - Long Island, at 259 1st St, Mineola, NY 11501 in Nassau County. The practice phone is (516) 576-1820.

Dr. Medranda's primary practice is NYU Langone Hospitals - Long Island in Mineola, New York. Dr. Medranda is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Medranda to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Medranda practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Medranda's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Medranda is licensed in New York.

CMS data shows 1,601 Medicare services from Dr. Medranda across 15 procedure codes in 2024, for 610 Medicare patients. Medicare paid $173,344 for them.

CMS counts 610 Medicare patients who saw Dr. Medranda in 2024. The largest group is 75 to 84, with 228 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Medranda's median patient age at 71, with 41% women.

In 2024, Dr. Medranda wrote 711 Medicare Part D claims for 164 patients. 93% of them were for generic drugs. CMS names the drug for 621 of them, across 13 drugs with 11 or more claims each, at $60,696 in total drug cost. In 2023, CMS named 438 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Medranda for performance year 2024, reported as part of a group. Dr. Medranda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 17 procedures of coronary angioplasty and stenting by Dr. Medranda, more than 44% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 217 general payments to Dr. Medranda from 27 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 84% of the total. Abbott Laboratories paid the most, $4,287.

Dr. Medranda graduated from State University of New York Downstate Medical Center College of Medicine in 2014.